Press
by Camille Sweeney, December 31, 2008
Leadership
From my first interaction with lasers used in ophthalmology over thirty years ago to non-invasive lasers used today that help relieve pain, reduce swelling, and heal wounds, I have always been fascinated about how to harness the full potential of light to help heal people.
Over the past decade I have helped numerous clients realize their product designs, taught Doctors, clinicians and technicians how lasers work and interact with the body, helped companies find “best in class” design and manufacturing firms to produce prototypes and productions systems of their innovative systems. Now, with Oculatek™, I hope to bring proven and innovative treatment to under-addressed patients. I hope you will join me.
-Jim Ohneck, CEO
For Doctors
Proven Care:
Easy Integration
Already an established treatment method in Europe associated with the Helmholtz Institute, Oculatek™ provides care to patients without the need for invasive surgery. Be one of our first test sites by contacting our team.
Oculatek™ provides a simple, non-invasive solution to your patients who suffer from presbyopia or myopia. Easy treatments are completed in two weeks, with one follow-up treatment recommended every six months.
If you are looking to:
Provide a non-surgical option for your patients
Be one of the first practices to offer this innovative solution
Add an additional revenue stream by diversifying care options
Improve patient relationships with frequent touch-bases
then Oculatek™ may be right for you. Studies have shown immediate improvement across multiple demographics, including early studies such as “Trans-scleral Laser Effects on Weakened Ciliary Muscle”, G. L. Gubkina. Feel free to download our support document which explores these studies, or contact a team member to field your questions.